United Therapeutics Corporation Other Revenue, Net (Deprecated 2018-01-31)
United Therapeutics Corporation (UTHR) reported Other Revenue, Net (Deprecated 2018-01-31) of $5.20 million for the 12-month period ending 2015-12-31, per its 10-K filed 2018-02-21.
Discontinued › Income Statement › Other Income
us-gaap:OtherSalesRevenueNet · last filed 2018-02-21
- United Therapeutics Corporation other revenue, net (deprecated 2018-01-31) for the quarter ending 2015-12-31 was $700.00K, a 29.72% decline year-over-year.
- United Therapeutics Corporation other revenue, net (deprecated 2018-01-31) for the quarter ending 2015-09-30 was $1.50M, a 10.77% decline year-over-year.
- United Therapeutics Corporation other revenue, net (deprecated 2018-01-31) for the quarter ending 2015-06-30 was $1.40M, a 4.96% decline year-over-year.
- United Therapeutics Corporation other revenue, net (deprecated 2018-01-31) for the quarter ending 2015-03-31 was $1.60M, a 67.01% decline year-over-year.
- United Therapeutics Corporation other revenue, net (deprecated 2018-01-31) for fiscal 2015 was $5.20M, a 42.22% decline from fiscal 2014.
- United Therapeutics Corporation other revenue, net (deprecated 2018-01-31) for fiscal 2014 was $9.00M, a 10.36% decline from fiscal 2013.
- United Therapeutics Corporation other revenue, net (deprecated 2018-01-31) for fiscal 2013 was $10.04M, a 0.87% increase from fiscal 2012.
- United Therapeutics Corporation other revenue, net (deprecated 2018-01-31) for fiscal 2012 was $9.95M, a 376.45% increase from fiscal 2011.
| Period end | Other Revenue, Net (Deprecated 2018-01-31) 3 month | Other Revenue, Net (Deprecated 2018-01-31) 3 month as first filed | Other Revenue, Net (Deprecated 2018-01-31) 6 month | Other Revenue, Net (Deprecated 2018-01-31) 6 month as first filed | Other Revenue, Net (Deprecated 2018-01-31) 9 month | Other Revenue, Net (Deprecated 2018-01-31) 9 month as first filed | Other Revenue, Net (Deprecated 2018-01-31) 12 month | Other Revenue, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $2.20M derived: sum of 2 quarters · filed 2018-02-21 | $3.60M derived: sum of 3 quarters · filed 2018-02-21 | $5.20M 10-K · filed 2018-02-21 | $5.19M 10-K · filed 2016-02-25 | |||
| 2015-09-30 | $1.50M 10-Q · filed 2016-10-27 | $1.51M 10-Q · filed 2015-10-27 | $2.90M derived: sum of 2 quarters · filed 2016-10-27 | $4.50M 10-Q · filed 2016-10-27 | $4.51M 10-Q · filed 2015-10-27 | $5.50M derived: sum of 4 quarters · filed 2017-02-22 | ||
| 2015-06-30 | $1.40M 10-Q · filed 2016-07-28 | $1.41M 10-Q · filed 2015-07-28 | $3.00M 10-Q · filed 2016-07-28 | $3.00M 10-Q · filed 2015-07-28 | $4.00M derived: sum of 3 quarters · filed 2017-02-22 | $5.68M derived: sum of 4 quarters · filed 2017-02-22 | ||
| 2015-03-31 | $1.60M 10-Q · filed 2016-04-28 | $1.59M 10-Q · filed 2015-04-28 | $2.60M derived: sum of 2 quarters · filed 2017-02-22 | $4.28M derived: sum of 3 quarters · filed 2017-02-22 | $5.75M derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2014-12-31 | $996.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $2.68M derived: sum of 2 quarters · filed 2017-02-22 | $4.15M derived: sum of 3 quarters · filed 2017-02-22 | $9.00M 10-K · filed 2017-02-22 | $8.99M 10-K · filed 2015-02-24 | |||
| 2014-09-30 | $1.68M 10-Q · filed 2015-10-27 | $3.15M derived: sum of 2 quarters · filed 2015-10-27 | $8.00M 10-Q · filed 2015-10-27 | $10.72M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-06-30 | $1.47M 10-Q · filed 2015-07-28 | $6.32M 10-Q · filed 2015-07-28 | $9.04M derived: sum of 3 quarters · filed 2016-02-25 | $11.26M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-03-31 | $4.85M 10-Q · filed 2015-04-28 | $7.57M derived: sum of 2 quarters · filed 2016-02-25 | $9.79M derived: sum of 3 quarters · filed 2016-02-25 | $12.90M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-12-31 | $2.72M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $4.94M derived: sum of 2 quarters · filed 2016-02-25 | $8.05M derived: sum of 3 quarters · filed 2016-02-25 | $10.04M 10-K · filed 2016-02-25 | ||||
| 2013-09-30 | $2.22M 10-Q · filed 2014-10-28 | $5.33M derived: sum of 2 quarters · filed 2014-10-28 | $7.32M 10-Q · filed 2014-10-28 | $10.71M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | $3.11M 10-Q · filed 2014-07-29 | $5.10M 10-Q · filed 2014-07-29 | $8.49M derived: sum of 3 quarters · filed 2015-02-24 | $10.04M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | $1.99M 10-Q · filed 2014-04-29 | $5.38M derived: sum of 2 quarters · filed 2015-02-24 | $6.93M derived: sum of 3 quarters · filed 2015-02-24 | $10.67M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2012-12-31 | $3.39M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $4.94M derived: sum of 2 quarters · filed 2015-02-24 | $8.68M derived: sum of 3 quarters · filed 2015-02-24 | $9.95M 10-K · filed 2015-02-24 | ||||
| 2012-09-30 | $1.55M 10-Q · filed 2013-10-29 | $5.30M derived: sum of 2 quarters · filed 2013-10-29 | $6.57M 10-Q · filed 2013-10-29 | $7.43M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | $3.75M 10-Q · filed 2013-07-25 | $5.02M 10-Q · filed 2013-07-25 | $5.88M derived: sum of 3 quarters · filed 2014-02-25 | $6.61M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | $1.27M 10-Q · filed 2013-04-25 | $2.14M derived: sum of 2 quarters · filed 2014-02-25 | $2.86M derived: sum of 3 quarters · filed 2014-02-25 | $3.07M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | $868.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $1.59M derived: sum of 2 quarters · filed 2014-02-25 | $1.79M derived: sum of 3 quarters · filed 2014-02-25 | $2.09M 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | $722.00K 10-Q · filed 2012-11-01 | $927.00K derived: sum of 2 quarters · filed 2012-11-01 | $1.22M 10-Q · filed 2012-11-01 | $1.51M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-06-30 | $205.00K 10-Q · filed 2012-07-26 | $499.00K 10-Q · filed 2012-07-26 | $793.00K derived: sum of 3 quarters · filed 2013-02-26 | $1.13M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-03-31 | $294.00K 10-Q · filed 2012-04-26 | $588.00K derived: sum of 2 quarters · filed 2013-02-26 | $927.00K derived: sum of 3 quarters · filed 2013-02-26 | |||||
| 2010-12-31 | $294.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $633.00K derived: sum of 2 quarters · filed 2013-02-26 | $1.20M 10-K · filed 2013-02-26 | |||||
| 2010-09-30 | $339.00K 10-Q · filed 2011-10-27 | $903.00K 10-Q · filed 2011-10-27 | ||||||
| 2009-12-31 | $1.24M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |